 |
|
Salicylate OtotoxicityA Clinical and Experimental Study
EUGENE N. MYERS, MD;
JOEL M. BERNSTEIN, MD
Arch Otolaryngol. 1965;82(5):483-493.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Introduction
SIXTEEN billion aspirin tablets are consumed in the United States annually.1 Fortunately, most people require the analgesic effect of aspirin only occasionally and then in small doses. However, the ingestion of large quantities of aspirin is necessary to achieve therapeutic success in the treatment of arthritis, rheumatic fever, and other connective tissue disorders. This same quantity of aspirin which relieves the pain of the underlying disease may also produce the annoying symptoms of hearing loss, tinnitus, and vertigo.
These symptoms are used by some rheumatologists to establish the proper dosage of this medication. The reversibility of these symptoms makes such a program possible. However, the concept that these symptoms are related to the dosage of salicylates and are reversible has not been well documented, and many physicians assume that these are idiosyncratic or allergic reactions.
A cinical study was undertaken to provide information that would be useful to
. . . [Full Text PDF of this Article]
Author Affiliations
BOSTON
From the Massachusetts Eye and Ear Infirmary and Harvard Medical School.
Footnotes
Submitted for publication Feb 16, 1965.
Read before the eighth annual meeting of the Committee for Research in Otolaryngology, American Academy of Ophthalmology and Otolaryngology, Oct 17, 1964.
Reprint requests to 97th General Hospital, APO 09757, New York, NY (Capt Myers).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
